Literature DB >> 7358845

Comparison of the microagglutination test with bactericidal response to Legionella pneumophila (Legionnaires disease bacterium).

D L Smalley, D D Ourth.   

Abstract

This investigation found that individuals with microagglutination antibody titers of 1:32 or greater to Legionella pneumophila produced bactericidal activity against the bacterium. Those individuals with microagglutination antibody titers of 1:16 or less demonstrated no bactericidal activity.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7358845      PMCID： PMC273356          DOI： 10.1128/jcm.11.2.200-201.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Primary isolation media for Legionnaires disease bacterium.

Authors:  J C Feeley; G W Gorman; R E Weaver; D C Mackel; H W Smith
Journal:  J Clin Microbiol       Date:  1978-09       Impact factor: 5.948

2.  Bactericidal antibody response to Pseudomonas aeruginosa by adults with urinary tract infections.

Authors:  D L Smalley; D D Ourth
Journal:  J Clin Microbiol       Date:  1979-08       Impact factor: 5.948

3.  Immunologic factors affecting the in-vivo and in-vitro survival of the Legionnaires' disease bacterium.

Authors:  R J Arko; K H Wong; J C Feeley
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

4.  Detection of antibodies to legionnaires disease organism by microagglutination and micro-enzyme-linked immunosorbent assay tests.

Authors:  C E Farshy; G C Klein; J C Feeley
Journal:  J Clin Microbiol       Date:  1978-04       Impact factor: 5.948

5.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

6.  Immunologic protection against the Legionnaires' disease bacterium in the AKR/J mouse.

Authors:  K W Hedlund; V G McGann; D S Copeland; S F Little; R G Allen
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

7.  Sporadic cases of Legionnaires' disease: the expanding clinical spectrum.

Authors:  D W Gregory; W Schaffner; R H Alford; A B Kaiser; Z A McGee
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391
  7 in total
  5 in total

1.  Immune defenses against Legionella pneumophila in rats.

Authors:  B Rolstad; B P Berdal
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

2.  Immunological nonidentity of Pseudomonas paucimobilis with Pseudomonas aeruginosa and Pseudomonas cepacia.

Authors:  D L Smalley; D D Ourth
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

3.  Comparison of microagglutination with the indirect immunofluorescence assay for the diagnosis of infection with Legionella pneumophila serogroup 1.

Authors:  N Bornstein; J Fleurette
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

4.  Prevalence of antibodies to Legionella pneumophila in animal populations.

Authors:  M T Collins; S N Cho; J S Reif
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

5.  Agglutinating antibody titers to members of the family Legionellaceae in cystic fibrosis patients as a result of cross-reacting antibodies to Pseudomonas aeruginosa.

Authors:  M T Collins; J McDonald; N Høiby; O Aalund
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.